期刊文献+

中国2010年卵巢癌发病与死亡分析 被引量:165

Incidence and Mortality of Ovarian Cancer in China,2010
原文传递
导出
摘要 [目的]估计2010年中国肿瘤登记地区卵巢癌的发病与死亡情况。[方法]根据全国肿瘤登记中心指定的审核方法和评估标准,对全国219个肿瘤登记处上报的2010年肿瘤登记数据进行评估,最终145个肿瘤登记处的数据纳入分析。将纳入的登记处按城乡、地区(东部、中部和西部地区)以及性别分层,计算各层卵巢癌的年龄别发病(死亡)率、结合全国人口,估计全国卵巢癌的发病(死亡)率、标化发病(死亡)率、构成比、累积发病(死亡)率。中国人口标化率(简称中标率)采用2000年全国普查标准人口年龄构成,世界人口标化率(简称世标率)采用Segi’s世界标准人口年龄构成。[结果]2010年入选年报的145个登记处(城市63个,农村82个),共覆盖人群158 403 248人(其中城市92 433 739人,农村65 969 509人),卵巢癌的M/I比例为0.45,MV%为81.18%,DOC%为1.71%,UB%为0.30%。据估计,2010年全国卵巢癌新发病例约4.15万例,死亡病例约1.76万例。卵巢癌发病率为6.47/10万,中标率为5.22/10万,世标率为4.97/10万,累积率(0~74岁)为0.53%。城市地区分别为7.73/10万、6.01/10万、5.73/10万、0.62%;农村地区分别为5.19/10万、4.32/10万、4.09/10万、0.42%。全国卵巢癌合计死亡率约为2.74/10万,中标率为2.08/10万,世标率为2.04/10万,累积率(0~74岁)为0.23%。城市地区分别为3.52/10万、2.51/10万、2.45/10万、0.28%;农村地区分别为1.94/10万、1.57/10万、1.54/10万、0.17%。[结论 ]2010年我国女性卵巢癌发病率和死亡率并不高,但因其较高的病死率严重威胁妇女的健康,应成为女性重点防治的恶性肿瘤之一。 [Purpose] To estimate the incidence and mortality of ovarian cancer in China in 2010.[Methods] On basis of the procedure of evaluation and criteria of data quality from NCCR,the data from 219 cancer registrations were checked and evaluated. There were 145 registries ' data qualified and accepted for this analysis. Incidence and mortality of ovarian cancer were calculated stratified by urban or rural,areas(eastern,middle,western) and age group. Cancer new cases and deaths were estimated using age-specific rate and national population in 2010. Chinese population sensus in 2000 and Segi's population were used for age-standardized incidence/mortality rate.[Results] All 145 caner registries covered of 158 403 248 populations(92 433 739 in urban areas,65 969 509 in rural areas). The M/I,MV%,DCO% and UB% accounted for 0.45,81.18%,1.71% and 0.30% respectively. It was estimated the total new cases and deaths of ovarian cancer were 41516 and 17558 respectively. The crude incidence in Chinese cancer registration areas was6.47/105,age-standardized incidence rate by Chinese standard population(ASR China) and by world standard population were 5.22/105 and 4.97/105 with the cumulative incidence rate(0~74 age years old) of 0.53%. The cancer incidence,ASR China and ASR world were 7.73/105, 6.01/105and5.73/105 in urban areas,whereas 5.19/105,4.32/105 and 4.09/105 in rural areas respectively. The cancer mortality in Chinese cancer registration areas was 2.74/105,age standardized mortality rate by Chinese standard population and world standard population were 2.08/105 and 2.04/105 with the cumulative incidence(0~74 age years old) of 0.23%. The cancer mortality,ASR China and ASR world were 3.52/105,2.51/105 and 2.45/105 in urban areas,whereas 1.94/105,1.57/105 and 1.54/105 in rural areas respectively. [Conclusion] The incidence and mortality of ovarian cancer are not high in China in 2010,but the high mortality is threatening women's health severely. Therefore,the prevention and treatment of ovarian cancer should be strengthened.
出处 《中国肿瘤》 CAS 2016年第3期169-173,共5页 China Cancer
关键词 卵巢肿瘤 发病率 死亡率 肿瘤登记 ovarian neoplasms incidence mortality cancer registration
  • 相关文献

参考文献11

  • 1Torte LA,Bray F,Siegel RL,et al. Global cancer statistics, 2012[J]. CA Cancer J Clin, 2015,65(2) : 87-108.
  • 2Chou JL,Su HY,Chen LY,et al. Promoter hypermethylation of FBX032,a novel TGF-p/SMAIM target gene and tumor suppressor,is associated with poor prognosis in human ovarian cancer[J]. Lab Invest, 2010,90(3) :414-425.
  • 3全国肿瘤登记中心.中国肿瘤登记工作指导手册[M].北京:中国协和医科大学出版社,2004.48-50.
  • 4Curado MPEB,Shin HR,Storm H,et al. Cancer Incidence in Five Continents, Vol. Ⅸ [M].Lyon : IARC Scientific Publications, 2008.
  • 5Bray F,Parkin DM. Evaluation of data quality in the cancer registry :principles and methods. Part Ⅰ :comparability,validity and timeliness [J]. Eur J Cancer,2009,45(5): 747-755.
  • 6Parkin DM,Chen VW,Ferlay J,et al. Comparability and quality control in cancer registration. IARC technical report No. 19[M]. Lyon : IARC, 1994.
  • 7Felay J,Burkhard C,Whelan S,et al. Check and Conversion Programs for Cancer Registries. IARC Technical Report No.42[M].Lyon : IARC, 2005.
  • 8Felay J. The IARCcrgTools program[EB/OL], http ://www.iacr.com.fr/iarccrgtools.htm. IACR. Lyon. 2006.
  • 9杨念念,严亚琼,郑荣寿,张思维,陈万青.中国2009年卵巢癌发病与死亡分析[J].中国肿瘤,2013,22(8):617-621. 被引量:58
  • 10杨念念,严亚琼,龚洁,张思维,郑荣寿,陈万青.中国2003~2007年卵巢癌发病与死亡分析[J].中国肿瘤,2012,21(6):401-405. 被引量:61

二级参考文献54

  • 1付岚,李俊英,李虹,余春华,向秋芬.社会支持与癌症患者生活质量的相关性研究及护理对策[J].中华护理杂志,2004,39(1):9-11. 被引量:335
  • 2苗青,孔北华.山东省上皮性卵巢癌发病因素分析——病例配对研究[J].癌症,2006,25(7):871-875. 被引量:8
  • 3李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 4Jemal A,Tiwari RC,Murray T,et al. Cancer statistics, 2004 [J]. Ca Cancer J Clin,2004,54(1): 8-29.
  • 5International Agency for Research on Cancer. GLOBO- CAN 2008[EB/OL]. http://www-dep.iarc.fr.
  • 6全国肿瘤登记中心.中国肿瘤登记工作指导手册[M].北京:中国协和医科大学出版社,2004.48-50.
  • 7Jemal A,Tiwari RC,Murray T,et al. Cancer statistics, 2004 [J]. Ca Cancer J Clin,2004,54(1): 8-29.
  • 8International Agency for Research on Cancer. GLOBO- CAN 2008. [EB/OI,]. http://www-dep.iarc.fr,2013-02-22.
  • 9Curado MPEB,Shin HR,Storm H,et al. Cancer Incidence in Five Continents,Vol. IX [M]. Lyon:IARC Scientific Publica- tions,2008.
  • 10Bray F,Parkin DM. Evaluation of data quality in the can- cer regist': Principles and methods. Part | : Comparabil- ity,validity and timeliness [J]. Eur J Cancer,2009,45(5): 747-755.

共引文献268

同被引文献1304

引证文献165

二级引证文献1186

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部